SKIP TO CONTENT
30+/SKIN
← ACTIVESRECORD A-05FAMILY DICARBOXYLIC ACID

Azelaic Acid

Azelaic Acid

ALSO — NONANEDIOIC ACID

Treats redness, post-inflammatory pigment and breakouts at once. Almost nothing else does all three.

WHERE WE SIT IN THE PUBLISHED RANGE5% ——— 20%
10%

We compound toward the middle of the published range, not the top of it. Past the point where the dose–response curve flattens, the extra percent buys irritation and nothing else.

IDENTITY & RATINGSA
INCIAzelaic Acid
FAMILYDicarboxylic acid
MOL. WEIGHT188.22 g/mol
HOUSE CONC.10% w/w
pH WINDOW4 – 5
ACTS ATEPIDERMIS
DEPTH15 – 140 µm
ONSET6–10 WK
STABILITYSTABLE
TRIALS ON FILE3
IRRITATION INDEX2 / 10
STRATUM CORNEUMEPIDERMISDERMIS

The shaded band is the depth this molecule is understood to reach. Anything below it is out of scope, whatever the label says.

01

Mechanism

EVIDENCE GRADE A

Competitive tyrosinase inhibitor with selectivity for hyperactive melanocytes. Antibacterial against C. acnes, normalises follicular keratinisation, scavenges reactive oxygen species.

HOUSE NOTES

  • Selectivity matters: it leaves normal melanocytes alone, so it does not lighten skin overall.
  • Grainy texture at 10% is the acid, not a defect. It dissolves on contact.

MEASURED ENDPOINTS

Inflammatory lesion count-41%
12 WKREF-05
Erythema index-22%
12 WKREF-08
Tyrosinase inhibition-63%
IN VITROREF-12

SUPPORTING RECORDS

  • Split-face, vehicle-controlled

    N=72 · 12 WK · INVESTIGATOR-BLIND

  • Randomised, vehicle-controlled

    N=88 · 12 WK · DOUBLE-BLIND

  • In vitro enzymatic assay

    N=12 · N/A · N/A

02

Layering

CONFLICTS & PAIRINGS
DO NOT LAYER

No known conflicts. This one goes next to anything in the formulary, in any order, on any night.

03

Compounded into

1 FORMULAS
SPECIMEN MONOGRAPH. FIGURES AND RECORDS ARE ILLUSTRATIVE PLACEHOLDERS AND CITE NO REAL STUDY, AUTHOR OR JOURNAL. NOT MEDICAL ADVICE.
DEPTH 000%SEC